Professor and Chairman, Stanford University School of Medicine - Ophthalmology
Professor Mark Blumenkranz is a Professor of Ophthalmology and Chairman at Stanford University School of Medicine. He is a practicing clinician in the USA at the Stanford Hospital and Clinics and Lucile Packard Children's Hospital.
His primary areas of interest are in the diagnosis, medical and surgical treatment of vitreal retinal diseases. These principally include age-related macular degeneration and other diseases of the macula, and tractional syndromes, diabetic retinopathy, and complex forms of retinal detachment. Professor Blumenkranz has been interested in the development of novel technology to diagnose and treat these diseases, including new forms of imaging, laser delivery systems, other microsurgical tools, and new drugs and drug delivery systems that inhibit new blood vessel growth, scarring and intraocular inflammation.
He has been actively involved in translational research in the laboratory as well as technology transfer associated with that research for a variety of new therapies that have received FDA clearance and been introduced into clinical practice over the past 30 years.
Professor Blumenkranz has been on the Board of Directors for a variety of voluntary education and service organisations, including the Corporation of Brown University, multiple scientific advisory boards and various philanthropic and research organisations.
Professor Blumenkranz has published over 40 articles in peer-reviewed journals and conference proceedings.
Professor Blumenkranz completed his certification with the American Board of Ophthalmology in 1980. Prior to this, he took residencies, fellowships and internships with Graduate Medical Education CA, the School of Medicine at Brown University, Stanford University and the Bascom Palmer Eye Institute. He completed his medical education at the School of Medicine at Brown University in 1975.